Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations ; volume:10 ; number:1 ; day:18 ; month:11 ; year:2020 ; pages:1-9 ; date:12.2020
Scientific reports ; 10, Heft 1 (18.11.2020), 1-9, 12.2020

Creator: Olsen, Dorte Aa
Thomsen, Caroline E. B.
Andersen, Rikke F.
Madsen, Jonna S.
Jakobsen, Anders
Brandslund, Ivan

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-020-77109-8

URN: urn:nbn:de:101:1-2020122320203931823600

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Olsen, Dorte Aa
Thomsen, Caroline E. B.
Andersen, Rikke F.
Madsen, Jonna S.
Jakobsen, Anders
Brandslund, Ivan
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Hochschulschrift

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Hochschulschrift

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Hochschulschrift

Functional characterization of BRAF mutations in multiple myeloma

Hochschulschrift

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Hochschulschrift

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Functional characterization of BRAF mutations in multiple myeloma

Functional characterizations of BRAF mutations in multiple myeloma

Clinical significance of BRAF mutations in metastatic melanoma

Targeted Therapy for Melanomas Without BRAF V600 Mutations

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Decreased serum concentrations of sphingosine-1-phosphate in sepsis

BRAF mutations in thyroid tumors from an ethnically diverse group

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Intracellular osmoprotectant concentrations determine Propionibacterium freudenreichii survival during drying

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF

Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations

Related objects

Reset password